93 related articles for article (PubMed ID: 20484184)
41. Benzbromarone therapy in management of refractory gout.
Kumar S; Ng J; Gow P
N Z Med J; 2005 Jun; 118(1217):U1528. PubMed ID: 15980902
[TBL] [Abstract][Full Text] [Related]
42. [Anti hyperuricemic agents].
Ogino K; Hisatome I; Shigemasa C
Nihon Rinsho; 2003 Jan; 61 Suppl 1():197-201. PubMed ID: 12629717
[No Abstract] [Full Text] [Related]
43. [Effect of benzbromarone on serum uric acid level and uric acid excretion of patients with gout].
Zöllner N; Griebsch A; Fink JK
Dtsch Med Wochenschr; 1970 Nov; 95(48):2405-12. PubMed ID: 5480261
[No Abstract] [Full Text] [Related]
44. Benzbromarone: availability for general prescribing in New Zealand (a response to letters by Dr Lance Gravatt onbenzbromarone).
Day R; Lee H; Graham G; Williams K
N Z Med J; 2013 Sep; 126(1382):124-6. PubMed ID: 24154781
[No Abstract] [Full Text] [Related]
45. Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol.
Reinders MK; van Roon EN; Jansen TL; Delsing J; Griep EN; Hoekstra M; van de Laar MA; Brouwers JR
Ann Rheum Dis; 2009 Jan; 68(1):51-6. PubMed ID: 18250112
[TBL] [Abstract][Full Text] [Related]
46. [Effects and side effects of benzbromaron in the initial treatment of hyperuricemia and gout. Results of a field study on 3899 patients].
Matzkies F
Fortschr Med; 1978 Aug; 96(32):1619-21. PubMed ID: 680625
[TBL] [Abstract][Full Text] [Related]
47. [Assessment on the clinical efficacy and safety of xiezhuo chubi recipe in treating hyperuricemia].
Zhang XX; Sun WF; Xu W
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Sep; 31(9):1216-9. PubMed ID: 22013799
[TBL] [Abstract][Full Text] [Related]
48. [Treatment of hyperuricemia using daily doses of 50 and 25mg of benzbromarone].
Matzkies F; Berg G; Minzlaff R
Fortschr Med; 1977 Jul; 95(27):1748-50. PubMed ID: 332605
[TBL] [Abstract][Full Text] [Related]
49. [Clinical studies on hyperuricemia and gout after transplantation].
Imanishi M; Ikegami M; Ishii T; Nishioka T; Uemura T; Kunikata S; Kanda H; Matsuura T; Akiyama T; Kurita T
Hinyokika Kiyo; 1990 Aug; 36(8):893-6. PubMed ID: 2239590
[TBL] [Abstract][Full Text] [Related]
50. Hyperuricemia associated with high cardiac event rates in the elderly with chronic heart failure.
Niizeki T; Takeishi Y; Arimoto T; Okuyama H; Nozaki N; Hirono O; Tsunoda Y; Watanabe T; Nitobe J; Miyashita T; Takahashi H; Koyama Y; Kubota I
J Cardiol; 2006 May; 47(5):219-28. PubMed ID: 16764328
[TBL] [Abstract][Full Text] [Related]
51. [Effectiveness and tolerance of long-term uricosuric treatment].
Berg H
Z Gesamte Inn Med; 1990 Dec; 45(23):719-20. PubMed ID: 2102029
[TBL] [Abstract][Full Text] [Related]
52. [Treatment of hyperuricemia and gout].
Gröbner W; Walter-Sack I
Med Monatsschr Pharm; 2005 May; 28(5):159-64; quiz 165-6. PubMed ID: 15912988
[No Abstract] [Full Text] [Related]
53. Hyperuricaemia and preeclampsia: is there a pathogenic link?
Schackis RC
Med Hypotheses; 2004; 63(2):239-44. PubMed ID: 15236782
[TBL] [Abstract][Full Text] [Related]
54. [The effect of benzbromarone on hyperlipidemia in gout].
Marinchev L; Kŭnev K
Vutr Boles; 1990; 29(5):99-102. PubMed ID: 2080622
[TBL] [Abstract][Full Text] [Related]
55. [Pathogenesis and treatment of fast-induced hyperuricemia using benzbromarone].
Schräpler P; Schulz E
Med Welt; 1976 Mar; 27(12):575-81. PubMed ID: 1263801
[No Abstract] [Full Text] [Related]
56. [Uric acid 8.4 in an asymptomatic patient. Does he need medication?].
Füessl HS
MMW Fortschr Med; 2012 Jun; O 154 Suppl 2():22. PubMed ID: 22916420
[No Abstract] [Full Text] [Related]
57. [The treatment of hyperuricemia after kidney transplantation].
Flury W; Ruch HR; Montandon A
Schweiz Med Wochenschr; 1977 Sep; 107(38):1339-41. PubMed ID: 335500
[TBL] [Abstract][Full Text] [Related]
58. [Uric acid lowering effects of benzbromarone (Harolan) by increasing uric acid excretion].
Fortschr Med; 1979 May; 97(17):835-6. PubMed ID: 437646
[No Abstract] [Full Text] [Related]
59. A double-blind placebo-controlled pilot study of controlled-release paroxetine on depression and quality of life in chronic heart failure.
Gottlieb SS; Kop WJ; Thomas SA; Katzen S; Vesely MR; Greenberg N; Marshall J; Cines M; Minshall S
Am Heart J; 2007 May; 153(5):868-73. PubMed ID: 17452166
[TBL] [Abstract][Full Text] [Related]
60. Bibliography. Current world literature. Crystal deposition disease.
Curr Opin Rheumatol; 2008 Mar; 20(2):226-31. PubMed ID: 18357635
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
